AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
KOS PHARMACEUTICALS INC. Miami, Florida; Focus On Cholesterol Pays Off For Drug Maker.(THE NEW AMERICA)
Byline: GLORIA LAU
Some drug makers rely on a host of medicines to drive growth. Not so with specialty drug maker Kos Pharmaceuticals Inc.
Its lead drug is Niaspan, for abnormally high cholesterol levels. The drug is a once-daily extended release formula of niacin -- an old product available over the counter.
Last year Niaspan accounted for 83% of Kos' $173 million revenue. In mid-June, Kos won regulatory approval to start selling Niaspan in Britain.
Kos' second drug, Advicor, combines Niaspan with lovastatin, a statin drug that reduces LDL, the "bad" cholesterol levels. Statins are known as the most effective class of reducing bad cholesterol levels. Advicor accounts for the remaining $30 million in yearly sales.
"We're neither a big pharmaceutical company nor a generic company," said Adrian Adams, Kos' chief executive. "We're right in between.
"A generic company will just copy an existing product and not raise the bar in terms of what the product offers. And they'll just bring that to market. We take existing products and improve the profile of the product."
- Kos Announces Introduction of Niaspan In Canada.
- Press release article from: Business Wire April 26, 2005 700+ words
...market all three doses of Kos' Niaspan(R) product (niacin extended...the products in Canada. Niaspan, internally developed by Kos, is indicated in Canada...C levels nearly 30%. Kos launched Niaspan in the United States in 1997...
- Kos' Niaspan(R) Achieves Formulary Status With Veterans Affairs And All...
- Press release article from: PR Newswire January 6, 2000 700+ words
...managers in the United States. Kos estimates that Niaspan is now automatically reimbursable...significant accomplishments for Kos and Niaspan," commented Daniel M. Bell...s strong sales growth." Kos' Niaspan product, which is the only...
- Kos Receives Final Approval to Launch Niaspan in Germany.
- Press release article from: Business Wire April 27, 2004 700+ words
...States and marks another key milestone for Kos. Niaspan, developed and manufactured by Kos, is indicated in the German label for...represents another major milestone for Kos in that it brings Niaspan, our highly differentiated, safe and...
- Kos' Niaspan(R) Achieves Formulary Status With Department of Defense; --...
- Press release article from: PR Newswire March 20, 2003 700+ words
...in the United States. Kos estimates that Niaspan is now officially approved...milestone achieved for Kos, and is a strong reflection of Niaspan's unique patient benefits...organization that will enable Kos to continue Niaspan's strong sales growth...
- Kos' Niaspan Launched in the United Kingdom; Brings Effective HDL Cholesterol...
- Press release article from: Business Wire November 3, 2003 700+ words
...last twelve months. Niaspan, developed and manufactured by Kos is indicated in the...agreement in 2002 with Kos for world-wide marketing rights to both Niaspan and Advicor(R...major milestone for Kos in that it brings Niaspan, the most effective...
- Six Years and 10 Million Prescriptions Affirm the Safety and Efficacy of Kos'...
- Press release article from: Business Wire July 2, 2003 700+ words
...safety and efficacy of Kos' products. The...Medicine showed that Niaspan alone or in combination...marketing approval for Niaspan in the United Kingdom...major milestone for Kos Pharmaceuticals...currently markets Niaspan and Advicor(TM...cholesterol disorders. Kos is developing ...
- Kos Receives Final Approval to Market Niaspan in France, Second Largest Market...
- Press release article from: Business Wire October 14, 2004 700+ words
...in the territory. Niaspan, developed and manufactured by Kos, is indicated in...levels up to 30%. Kos launched Niaspan in the United States...the fall of 2002, Kos and Merck KGaA entered...and distribute both Niaspan and Advicor(R...
- Kos Pharmaceuticals and Takeda Pharmaceuticals North America Announce...
- Press release article from: Business Wire November 4, 2003 700+ words
...agreement to co-promote Kos' Niaspan(R)and Advicor(R) in...representatives to the existing Kos sales force to detail Niaspan (extended-release niacin...ACTOS, but also detail Kos' Advicor and Niaspan. TPNA is responsible for...